Finance

Decorative

The New Normal Is Still Ours to Define

There is no new normal. Not yet. It is too soon to put the physical, emotional, and financial disruption in one column and the heroism, innovation, and health-care advances in another and sum them up. Whether in the public or private sector...
Read Essay
Image
A light-skinned male with no hair wearing a dark suit and tie against an abstract background

Mark Machin

President and CEO, CPP Investments

The Global Credit Crunch

.bubble-images, .bubble-images img { border-radius: 50%; } The Global Credit Crunch Friday, April 17 | 8:30 am (Singapore Time) In just four weeks, COVID-19 has thrown the credit markets into disarray. The US 10-year treasury yield dropped...
View Webinar

Capital and COVID-19

.bubble-images, .bubble-images img { border-radius: 50%; } Capital and COVID-19 Monday, March 30, 2020 | 7:30 am PST Our latest conference call focused on the market implications of COVID-19. Moderated by Michael Piwowar, executive director...
View Webinar
Decorative

Staying the (Long) Course

I have every confidence that our society, our communities, and our businesses will emerge from the COVID-19 pandemic stronger, more resilient, and more innovative than we were before it. But it’s going to take time and a lot of hard work...
Read Essay
Image
A smiling light-skinned female with dark brown hair wearing glasses and a blue shirt against an abstract background

Jane Fraser

President, Citigroup and CEO, Global Consumer Banking, Citi

Michael Milken Engages Crisis Leaders in New Podcast

Responding to COVID-19: Conversations with Mike Milken features medical research, business, and public policy leaders LOS ANGELES, April 7, 2020 – The Milken Institute today introduced a new program focusing on leaders in the war against...
Read Article
Image
A smiling caucasian male-presenting individual wearing a dark suit and tie against a bright blue and black background

Mike Milken

Chairman
Mike Milken, chairman of the Milken Institute, has been at the forefront of successful initiatives in medical research, education, public health and access to capital for more than four decades. Fortune called him “The Man Who Changed Medicine” and Forbes listed him among “Visionaries Reimagining Our Children’s Future.”